This inventor holds 5 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Farmalider, S.a., Other. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2026
Title: Nuria Sanz Menéndez: Innovator in Pharmaceutical Treatments
Introduction
Nuria Sanz Menéndez is a prominent inventor based in Alcobendas, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in pain management and treatment for osteoarthritis. With a total of 5 patents, her work has had a meaningful impact on patient care.
Latest Patents
One of her latest patents involves the use of montelukast for the treatment of erosive hand osteoarthritis. This invention details how montelukast can be administered either orally or topically, in various pharmaceutical compositions. Patients suffering from this condition have reported improvements in clinical symptoms, radiological parameters, pain relief, and enhanced hand functionality.
Another notable patent is the combination of ibuprofen and tramadol for relieving pain. This invention specifies the dosages of ibuprofen and tramadol, making it suitable for treating moderate to severe pain, whether chronic or acute. The fixed-dose combination has proven particularly effective for patients experiencing intense pain.
Career Highlights
Throughout her career, Nuria has worked with various companies, including Farmalider, S.A. Her experience in the pharmaceutical industry has allowed her to develop innovative solutions that address critical health issues.
Collaborations
Nuria has collaborated with notable coworkers such as Antonia Gómez Calvo and José Ángel Sánchez García. Their teamwork has contributed to the successful development of her patents and innovations.
Conclusion
Nuria Sanz Menéndez is a trailblazer in the pharmaceutical field, with her inventions significantly improving treatment options for patients. Her dedication to innovation continues to inspire advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile